GlassScriptPhysician profile
Chris Brussow
NPI 1346726023
$1,370.25
in general payments reported to CMS, 2019-2025
14 companies · $94.35 in 2025
The $94.35 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $442 · 2023: $401 · 2024: $138 · 2025: $94.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $401.28 | 2021-2025 | Farxiga |
| Glaxosmithkline, LLC. | $283.94 | 2021-2023 | Arexvy |
| Abbvie INC. | $134.42 | 2023-2024 | Qulipta, Ubrelvy, Linzess |
| Pfizer INC. | $103.10 | 2021-2025 | |
| Amgen INC. | $93.41 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.99 | 2022-2023 | |
| Sanofi Pasteur INC. | $53.98 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $42.24 | 2023-2024 | Rexulti |
| Novo Nordisk INC | $34.63 | 2023-2024 | Wegovy |
| Exact Sciences Corporation | $21.85 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $21.42 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Lilly USA, LLC | $19.13 | 2025 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $17.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Brussow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.